L. Eltaib

Discovery of dual-target natural inhibitors of meprins α and β metalloproteases for inflammation regulation: pharmacophore modelling, molecular docking, ADME prediction, and molecular dynamics studies.

A. A. Alzain, L. Eltaib, 2023, SAR and QSAR in environmental research.

Overcoming chemoresistance and radio resistance in prostate cancer: The emergent role of non-coding RNAs.

Abida, Shams Aaghaz, Arbi Guetat, 2024, Pathology, research and practice.

Repurposing Anti-Dengue Compounds against Monkeypox Virus Targeting Core Cysteine Protease

N. Alotaibi, M. Imran, M. Kamal, 2023, Biomedicines.

Beyond the genome: MALAT1's role in advancing urologic cancer care.

Abida, A. Rabaan, A. Abdulkhaliq, 2024, Pathology, research and practice.

Resveratrol-Laden Nano-Systems in the Cancer Environment: Views and Reviews

Mohammed Sanad Alshammari, M. Kamal, Abuzer Ali, 2023, Cancers.

Long non-coding RNA HOTAIR: A biomarker and therapeutic target in urological tumors.

Abida, A. Rabaan, A. Abdulkhaliq, 2024, Pathology, research and practice.

Beyond traditional medications: exploring novel and potential inhibitors of trypanothione reductase (LmTr) of Leishmania parasites.

Abida, M. Bakht, Mohd Imran, 2024, Journal of biomolecular structure & dynamics.

Computer-assisted discovery of safe and effective DprE1/ aaRSs Inhibitors against TB utilizing Drug Repurposing approach.

Abida, N. Alotaibi, M. Imran, 2023, Journal of infection and public health.